Want to see SGRY full AI Analyst Report?
Surgery Partners (SGRY) Stock Forecast & Price Target
SGRY Analyst Ratings
SGRY Stock 12 Month Forecast
Average Price Target
$20.88▼(-9.75% Downside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Ryan Langston | TD Cowen | $19→$23.50 | hold | 1.60%Upside | Downgraded | 10/31/26 | ||
| A.J. Rice | UBS | $21→$23.50 | hold | 1.60%Upside | Downgraded | 10/27/26 | ||
| Ben Hendrix | RBC Capital | $19→$23.50 | hold | 1.60%Upside | Downgraded | 10/26/26 | ||
| Sarah James | Cantor Fitzgerald | $18→$23.50 | hold | 1.60%Upside | Downgraded | 10/26/26 | ||
| Andrew Mok CFA | Barclays | $14 | hold | -39.47%Downside | Reiterated | 10/07/26 | ||
| Joanna Gajuk | Bank of America Securities | $20 | buy | -13.53%Downside | Reiterated | 09/18/26 | ||
| Benjamin Rossi | J.P. Morgan | $14→$15 | hold | -35.15%Downside | Assigned | 09/14/26 | ||
| Matthew Gillmor CFA | KeyBanc | ― | hold | ― | Reiterated | 08/11/26 | ||
| Bill Sutherland | Benchmark Co. | $24 | buy | 3.76%Upside | Reiterated | 08/11/26 | ||
| Ann Hynes | Mizuho Securities | $19 | buy | -17.86%Downside | Reiterated | 07/13/26 | ||
| Brian Tanquilut | Jefferies | $15→$17 | buy | -26.50%Downside | Reiterated | 05/06/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Ryan LangstonTD Cowen | HoldDowngraded$19→$23.50 | 10/31/26 | 1.60%Upside | ||
| A.J. RiceUBS | HoldDowngraded$21→$23.50 | 10/27/26 | 1.60%Upside | ||
| Ben HendrixRBC Capital | HoldDowngraded$19→$23.50 | 10/26/26 | 1.60%Upside | ||
| Sarah JamesCantor Fitzgerald | HoldDowngraded$18→$23.50 | 10/26/26 | 1.60%Upside | ||
| Andrew Mok CFABarclays | HoldReiterated$14 | 10/07/26 | -39.47%Downside | ||
| Joanna GajukBank of America Securities | BuyReiterated$20 | 09/18/26 | -13.53%Downside | ||
| Benjamin RossiJ.P. Morgan | HoldAssigned$14→$15 | 09/14/26 | -35.15%Downside | ||
| Matthew Gillmor CFAKeyBanc | HoldReiterated | 08/11/26 | ― | ||
| Bill SutherlandBenchmark Co. | BuyReiterated$24 | 08/11/26 | 3.76%Upside | ||
| Ann HynesMizuho Securities | BuyReiterated$19 | 07/13/26 | -17.86%Downside | ||
| Brian TanquilutJefferies | BuyReiterated$15→$17 | 05/06/26 | -26.50%Downside |
Best Analysts Covering Surgery Partners
Copying Brian Tanquilut's trades and holding each position for 3 Months would result in 56.67% of your transactions generating a profit, with an average return of +7.20% per trade.
Copying Brian Tanquilut's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +17.36% per trade.
Copying Bill Sutherland's trades and holding each position for 2 Years would result in 37.93% of your transactions generating a profit, with an average return of -0.06% per trade.
SGRY Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 2 | 1 |
| Buy | 6 | 4 | 6 | 5 | 2 |
| Hold | 2 | 2 | 3 | 8 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 8 | 7 | 11 | 15 | 9 |
In the current month, SGRY has received 3 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. SGRY average Analyst price target in the past 3 months is 20.88.
SGRY Financial Forecast
SGRY Earnings Forecast
Next quarter’s earnings estimate for SGRY is $0.11 with a range of $0.07 to $0.14. The previous quarter’s EPS was $0.10. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
SGRY Sales Forecast
Next quarter’s sales forecast for SGRY is $820.96M with a range of $810.50M to $858.50M. The previous quarter’s sales results were $848.90M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
